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German Diabetes Association 
At the 6th Congress of the German Diabetes Association, which took place in Dfisseldorf from 14--16 May 1971 
under the Chairmanship of Prof. Dr. Karl  Jahnke, the following awards were presented: 
1. "Paul  Langerhans-Medal 1971" 
to Dr. Kaud  LU~DBAEK, Professor of Internal  Medicine, University of Aarhus, Denmark, for his research work on 
diabetic angiopathy. His lecture "Growth hormone and diabetic angiopathy" was held in memorandum of Paul  
Langerhans. 
2. "Ferdinand Bertram Award 1971" 
to Dr. Berend WxnL~s, Privat-Dozent at the University of GSttingen for research on the "Regulation of gluco- 
neogenesis". 
3. "Award of the German Diabetes Association 1971" 
to Dr. Michael BERGE~ for his thesis "Studies on the lipolysis in human adipose tissue in vitro", carried out at the 
Diabetes Research Inst i tute  of the University of Dfisseldorf. 
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Studies on the antilipolytie effect of insulin in human 
adipose tissue 
J. (~stmann, E. Cerasi, S. EfendiS, R. Luft. Department  
of Endocrinology and Metabolism, Karolinska Hospital, 
S-10401 Stockholm 60, Sweden. 
The inhibitory effect of glucose on the mobilization of 
lipids from the fat depots #n v~vo has been at tr ibuted to 
either increased release of insulin, and/or changes in the 
sympathetic tone to adipose tissue. In  favour of the 
latter hypothesis are the observations that  glucose in- 
fusion suppresses the plasma-glycerol concentration as 
markedly in subjects with low insulin response to glucose 
as in subjects with normal insulin response. Previous work 
in this laboratory has demonstrated that  the eatechol- 
amines: 1. stimulate lipolysis in isolated human adipose 
tissue via the beta-s~Irenergic receptors, and 2. inhibit  
this process via the alpha-receptors. The question arises 
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whether the antilipobutic effect of insulin in human ad- 
ipose tissue is localized at  the site(s) of the adrenergic 
receptors. 
Sections of subcutaneous adipose tissue removed during 
surgical operation were incubated with no glucose added 
to the medium. Glycerol release was taken as an  index of 
lipolysis. Physiological concentrations of insulin (10-- I00 
~U/ml) were shown to:  1. inhibit  lipolysis induced by  
noradrenaline, 2. if anything,  stimulate lipolysis induced 
by  isopropylnoradrenaline, 3. have no influence upon 
tipolysis stimulated by  dibutyryl-cAMP, and 4. inhibit  
basal lipolysis. 
The inhibitory effect of insulin on noradremaline-induced 
lipolysis was reduced by increasing concentrations of the 
alpha-adrenerglc blocking agent phentolamine in the 
medium. 
The possible sites of the antilipolytie effect of insulin in 
human adipose tissue will be discussed. 
The effect of insulin and some insulin derivatives on the 
glucose metabolism and the lipolysis in rat isolated fat 
cells. 
J .H .  Nielsen. Steno Memorial Hospital, Research labora- 
tory, Gentofte, Denmark. 
The effect of insulin, proinsulln and photo-oxidized insulin 
on the formation of CO~ and lipid from 14C-l-labelled 
lueose is compared with the antilipolytie effect against 
CTH-induecd lipolysis in absence of glucose. In  pro- 
portion to the effect of pork insulin, pork proinsulin 
showed an activity of about  1 per cent with respect to 
both glucose metabolism and antilipolysis. Photo. 
oxidized insulin derivatives in which 63 per cent and 
6 per cent of the histidyl residues were intact  showed 
activities of about 35 per cent and 3 per cent respectively 
in both effects. Their ability to compete with nsI-insulin 
for insulin antibodies ~ s  similarly reduced. These results 
are in agreement with the hypothesis tha t  the effect of 
insulin on glucose transport  and the antilipolytie effect 
in absence of glucose require the same molecular structure 
and are effectuated via the same receptors. 
Adipose tissue fat cell size and number in relation to 
metabolism. 
P. Bj6nltorp,  L. Sj6str5m. First Medical Service, Sahl- 
gren's Hospital, University of Gothenburg, Gothenburg, 
Sweden. 
Fa t  cell size was measured in different regions of sub- 
cutanoues adipose tissue. An estimate of total  number  of 
fat cells was calculated by  dividing body fat, obtained 
by isotopic dilution methods, by  a representative average 
fat cell weight. 
I n  the normal region body fat correlated significantly 
with both fat cell number  and size. With body fat > 20 kg 
correlations were again found with cell number  although 
fat cell size had here levelled off on a constant, enlarged 
size. Taken togethea" these results indicate that  with 
moderately enlarged body fat (20--40 kg) fat cell size is 
the dominating factor contributing to increase of adipose 
tissue whereas with severe obesity cell number  is the more 
important  factor. 
Physically t raining middle-aged men was followed with 
fat cell size determinations while decreasing in weight. 
~Zhen weight constant after 6--  12 months they had small 
fat cells with a narrow range (0.3--0.5 ~g). This was 
characteristic also of middle-aged and young, weight- 
stable athletes. Patients with endogenous hypertrigly- 
cerida~mia and adult-onset diabetes mellitus were, how- 
ever, characterized by enlarged fat cells. 
Associations were found between fasting plasma insulin 
or sum of insulin during glucose tolerance test and fat 
cell size. These associations were stronger than those 
between insulin and body fat. Furthermore, insulin was 
usuMly positively correlated with plasma triglycerides. 
No positive correlations were found with fat cell number  
arid metabolic variables. Cholesterol and glucose tolerance 
did not  correlate with adipose tissue factors. 
I t  is suggested that  the adipose tissue factor which is 
associated ~,~;ith metabolic disturbances is the enlargement 
of fat cells. 
Protein kinase as a regulatory enzyme for insulin stimula- 
tion of glycogen synthesis in muscle. 
E. ~ralaas, O. V~Tala~s. Inst i tute  for Medical Biochemistry, 
Universi ty of Oslo, Nol~vay. 
Insul in  favours glycogen synthesis in muscle by promoting 
D-~I  conversion of glycogen synthetase. This enzyme is 
subjected to reversible phosphorylation (D-form) azid 
dephosphorylation (I-form) reactions by the action of a 
kinase and a phosphatase. Since glycogen synthetase 
kinase has recently been identified as a cyclic AMP- 
dependent protein kinase, the effect of insulin on this 
enzyme has been investigated. Intact, rat  diaphragm 
preparations were incubated in the absence and the 
presence of insulin (0.1 U/ml) for 10 mln in the absence 
of glucose. Extracts of the diaphragms were then prepared 
and partial purification of protein kinase was performed. 
Protein kinase has been shown to be converted from an 
inactive to an active form under the influence of cyclic 
AMP. Therefore, the amount  of inactive form of the 
enzyme from the diaphragm was determined by its capa- 
city of binding alt-c_&MP as well as by the cyclic AMP. 
dependent phosphorylation of histone. The experiments 
have shown that  insulin promotes an increase of the 
inactive form of protein kinase in the diaphragm to an 
extent of 50 per cent conversion. This inactivation of 
protein kinase by  insulin promotes activation of glycogen 
synthetase and decreased activity of phosphorylase b 
kinase resulting in st imulation of glycogen synthesis. The 
effect of insulin on protein kinase seems to provide 
more general mechanism for metabolic effects of insulin, 
such as decreased glycogenolysis, decreased gluconeo- 
genesis, decreased hepatic production of glucose and the 
presence of the antilipolytic effect. 
The activation by insulin of glycogen synthetase in the 
perfused rat liver 
A.T. Hostmark. Inst i tute  for Medical Biochemistry, 
University of Oslo, Norway. 
Bishop and Lamer have shown tha t  insulin in vivo 
augments the independent form (I-form) of glycogen 
synthetase without affecting the t~)tal (I + D) activity. 
This net  D ~ I  conversion might in theory result either 
from a st imulation of the D ~ I phosphatase, an inhibit ion 
of the t ~ D  kirmse or a combination of these effects. 
Using the perfused rat  liver we have found that  insulin 
effects a net  D -+I conversion, but  only if the liver is first 
stimulated with epinephrine. The total (I + D) activity 
was construct during the experiment. This epinephrine- 
insulin antagonism was found in the 48 h starved animal 
as well as in the animal fed ad libitum. The alpha-blocking 
agent, phentolamine (Regitin) was ~dded to the perfusion 
medium in order to abolish the marked vasoconstrictor 
effect of epinephrine. The drug did no t  modify the hor- 
mone effect on the synthetase. These experiments suggest 
an insulin effect upon the synthehuse kinase system. 
The effect of an~i-insulin serum and low glucose on 
glncokinase in rat liver studied by liver perfusion technique. 
O. Spydevold, G. Hoddevik. Inst i tute  for Medical :Bio- 
chemistry, Oslo, Norway. 
I t  is now well established that  the adaptat ion of high-Km 
hexokinase in rat  liver (glueokinase) is dependent on the 
presence of insulin az well as glucose. However, it is not  
yet clear which is the real "inducer" of the enzyme. Sols 
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et al. have shown by  a liver-slice incubation technique 
that  high glucose stabilizes the enzyme. Ruderman et al. 
have shown that  anti-insulin serum given intravenously 
to fed rats causes a fall in the enzyme activity within 3 h. 
A simultaneous elevation in F F A  level in plasma was 
found. By a perfusion technique Ruderman et al. also 
demonstrated that  insulin preserved the activity of 
glucokinase in isolated liver. 
To establish a possible correlation between the gluco- 
kinase activity and the FFA level in plasma and intra- 
cellular, 3 day fasted rats were refed a carbohydrate-rich 
diet. A decrease in F F A  level in plasma and intraeellular 
was observed within few hours of the refeeding period. The 
intracellular variation correlated inversely with the 
enzyme activity. However, perfusion of rat  liver with 
anti-insulin for five hours did not  affect the enzyme 
activity although the F F A  level in perfusion medium as 
well as intracellular was increased significantly. 
Perfusion experiments with shifting of the perfusion 
medium each 60 rain showed that  liver perfusions can be 
carried out for several hours with subnormal glucose 
concentrations without alteration in the enzyme activity, 
and the question of the significance of variation of glucose 
concentration within physiological limits can be raised. 
Adrenergic regulation of basal insulin secretion. 
I. Lundquist .  Department  of Pharmacology, University 
of Lund, Lund, Sweden. 
Vascular effects of cateeholamines have been classified 
into ~-adrenergic and fl-adrenergic according to the con- 
cept of the existence of different receptors mediating 
vasoconstriction (alpha) and vasodilatation (beta). Pan- 
creatic islet fl-cells are also known to contain both 
~-adrenergic and fl-adrenergic receptors inhibiting (alpha) 
or promoting (beta) insulin secretion. The possible physio- 
logical role of fl-adrenergic stimulation by the adrenergic 
system .is' however, unknown since the physiologicall, y 
synthesized catecholamines adrenaline and noradrenalme 
both have been reported solely to inhibit  insulin secretion. 
The present investigation was undertaken to test the 
possibility that  physiological catecholamines might have 
a dual action on insulin secretion, i.e. also an insulinogenic 
effect analogous to the depressor effect of adrenaline on 
the vascular system, "adrenaline reversal", which can be 
elicited with very small concentrations of the catechol- 
amine exciting only the fl-receptors. -- Administrat ion of 
the specific fl-adrenergie blocking agent L-propranolol to 
normal non-fasted mice decreased basal plasma insulin 
levels to about 50% of control values and elicited a mild 
hyperglycaemia. On the other hand, it potentiated the 
hypoglycaemic action of exogenously administered insulin 
in both normal and alloxan-diabetic animals. Another 
fl-reeeptor blocking drugL-alprenolol, possessing intrinsic 
sympathomimetie activity, had no effect on basal plasma 
insulin level. Similarly, the administrat ion of the D- 
isomers of the two drugs did not  influence plasma insulin 
levels. I n  vitro incubation of liver, muscle and adipose 
tissue from L-propranolol treated animals with labelled 
glucose showed an increased laCO2 production and 14C- 
incorporation into glycogen in muscle tissue compared 
to saline injected controls. :No significant change was 
recorded with liver or adipose tissue. The ~-blocking 
agent phentolamine increased basal plasma insulin levels 
and brought about a marked hypoglyeaemia. After pre- 
t reatment  with phentolamine, the intravenous injection 
of adrenaline or noradrenaline elicited a rapid and marked 
increase in plasma insulin concentration. Z-propranolol 
abolished phentolamine-induced insulin secretion. Adre- 
nalectomy was found to decrease basal plasma insulin 
levels. Moreover, the increased insulin secretion following 
phentolamine t reatment  was abolished in adrenalectomiz- 
ed and glucocorticosteroid-substituted adrenalectomized 
animals. -- The results obtained indicated that  adrenaline 
might have a dual action on insulin-secreting mechanisms 
analogous to its effect on the vascuLr system. In  addition, 
propranolol potentiation of insulin-induced hypoglyeaemia 
was interpreted as a result of increased glucose utilization 
and possibly glycogen preservation in muscle tissue. 
Correlation between hyperinsulinaemia and hyperphagia in 
rats after ventromedial hypothalamic lesions. 
A. Love, B.E.  Hustvedt.  Inst.  for Nutr. Res., Univ. of 
Oslo, Norway. 
Bilateral destruction of the ventromedial hypothalamic 
area in adult  rats produces hyperphagia and extreme 
obesity. Considerably elevated plasma immunoreactive 
insulin ( IgI )  levels have been reported in such animals. 
This hyperinsulinaemia has been explained either as a 
neuro-endocrine disturbance directly related to the 
hypothalamic operation or merely as a consequence of the 
altered food intake and body composition. In  our ex- 
periments, plasma levels of I R I  and glucose after 8 h 
fasting were determined in unrestrained rats equipped 
with chronically implanted venous catheters. Lesions 
were then made bilaterally in the ventromedial hypo- 
thalamie area by means of electrolysis. Food intake was 
restricted in order to prevent hyperphagia. An elevated 
I R I  level with only small changes in blood glucose was 
demonstrated 2 days after lesions. After 5 days on 
restricted food intake, the animals were given free access 
to food. A positive correlation was observed between the 
body weight gain of each animal following 3 days of ad lib. 
feeding and the individual increase in the fasting I R I  
concentration after lesion. However, the cause of the 
early elevation of plasma I R I  levels after ventromedial 
hypothalamic lesions remains to be established. 
Role of glucose in arginine-induced insulin release in man. 
S. Efendi6, E. Cerasi, R. Luft. Department  of Endo- 
crinology and Metabolism, Karolinska Hospital, S- 104 01 
Stockholm 60, Sweden. 
In  five healthy subjects the plasma insulin response to 
intravenous arginine was markedly diminished when the 
amino acid was administered during insulin-induced 
hypoglycaemia. This inhibition of insulin release was not  
due to the catecholamine secretion during hypoglycaemia 
since, in separate experiments, infusion of a large dose 
of epinephrine was unable to suppress significantly the 
insulin response to arginine. I t  is concluded that  the 
insulinogenie effect of arginine, for its expression, requires 
a normal blood glucose concentration. 
The close interrelationship between arginine and glucose 
regarding insulin secretion was further illustrated by the 
finding that  the insulin response to intravenous glucose 
infusion was markedly enhanced by prior administrat ion 
of arginine. In  experiments where hyperglycaemia was 
achieved through epinephrine infusion, no synergism 
could be observed between arginine and hyperglycaemia 
on insulin secretion. Immediately on cessation of epine- 
phrine infusion a prompt and marked insulin peak was 
obtained. These findings indicate that  synergism between 
arginine and glucose appears only when glucose itself is 
able to elicit insulin release. 
We suggest that  arginine stimulates insulin release by 
modulating the insulinogenic signal evoked by glucose in 
the fl-cell, and not  by a primary action of arginine itself 
on the insulin releasing machinery. 
Plasma insulin (IRI) response to small doses of intra- 
venous glucose and to tolbutamide in obesity. 
R. Pelkonen, E.A. Nikkila, M.-R. Taskinen. Third De- 
par tment  of Medicine, University of ]-Ielsinki, Helsinki, 
Finland.  
Islet cell hyperplasia and an exaggerated response of 
plasma immunoreactive insulin to various stimuli is 
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characteristic of human obesity. The purpose of the 
present investigation was to s tudy the sensitivity of 
insulin release mechanism in obese subjects by means of 
small doses of intravenous glucose and by comparing the 
insulogenic effect of intravenous tolbutamide and of high 
dose of intravenous glucose. 
Three successive doses of glucose (i,  2.5 and 5 g) were 
administered to i4  obese and i0 control subjects. In  both 
groups the smallest dose of glucose was already sufficient 
to increase the level of plasma I R I  within 2rain, although 
the content  of blood glucose was elevate] only minimally 
(average 5 m g / i 0 0  ml}. The insulin responses increased 
progressively by  increasing the dose of glucose and were 
gTeatest in the obese group. 
The early responses (from 2 to 10 min) of plasma I g I  to 
1 g of tolbutamide and to 25 g of intravenous glucose were 
compared in 16 obese and 11 control subjects. Calculation 
of the ratio of plasma I R I  response to glucose and to 
tolbus (IRIgluc/IRItolb) reveMed that  obese sub- 
jects were more sensitive to tolbutamide than to glucose 
compared with control subjects. 
I t  is concluded that  the secretion of ~ is very sen- 
sitive to small changes of blood glucose levels, and  that  
the obese subjects are more sensitive than  the lean sub- 
jects. One gram of tolbutaznide causes a greater insulin 
response than  25 g of glucose in obese bu t  not  in lean sub- 
jects. 
Insulin secretion during continuous infusion of isoprenallne 
in normal and diabetic subjects. 
S.N. Madsen, U.B. Lanridsen, T. Deckert. Medical De- 
par tment  E, Frederiksberg Hospital, Copenhagen. 
Serum insulin ( IgI )  and blood glucose (BG) was measured 
in 10 normal subjects and 7 maturi ty-onset  diabetics given 
a continuous infusion of isoprenallne 2 ~g/min before and 
during i.v. GTT with 25g of  glucose. As conffrol, Lv. GTT 
was carried out, during infusion of 0.9}/o NaC1 the day 
before. 
I n  the normal sub jec t ,  isoprenaline alone significantly 
increased I R I  above the basal level (p < 0.0025) without 
a concommitant  rise in BG. During i.v. GTT, serum 
insulin values also increased significantly (p < 0.01) al- 
though the BG did not  differ significantly from the control 
va lues .  
I n  ~he maturi ty-onset  diabetics, isoprenaline likewise 
increased I R I  without changes in BG, as well before as 
during i.v. GTT (iv < 0.05). The increase in IRI after 
isoprenaline was not significantly lower in diabetics than 
in non-dlabetics. 
The effect of work load severity upon Mood glucose and 
plasma insulin concentrations in exercising man. 
E.D.R .  Pruett .  Ins t i tu te  of Work Physiology, Oslo, 
Norway. 
During a series of metabolic studies involving healthy 
young male subjects in the post-absorptive state, changes 
in blood glucose and plasma immunoreac4ive insulin (IRI) 
concentrations were followed as the subjects exercised to, 
or nearly to, exhaustion at  various exactly measured 
work loads of from 2 0 ~  to 90% of the subject 's pre- 
viously measured maximal  oxygen upf~ake (max VOw). 
Exercise at  all work loads resulted in a decrease in plasma 
I R I  concentration irrespective of the concomittant  re- 
OnSe of blood glucose concgntra~on to the exercise. 
ereise to exhaustion at 50% and 70~o of the subject 's 
max ~rO~ was accompanied by  a decrease in blood glucose 
concentration to approximately 60% of the pre-exercase 
value. Exercise at work loads requiring utilization of 
85--90% of the subject 's max ~r(~, however, was ac- 
companied by  an  increase instead of  a decrease in blood 
glucose concentration by  the time exhaustion was reached. 
I t  was concluded that, during prolonged, severe muscular 
exercise, ether endogenous mechanisms in addition to 
blood glucose concentration, can regulate circulating 
plasma I R I  levels. 
The rate of disappearance of infused glucose after exercise. 
E.D.R .  Pruett .  Ins t i tu te  of Work Physiology, Oslo 
Norway, 
Glucose was infused 15 min  after the termination of 
exercise during a series of me~abohe studies invoIvfing 
healthy young men in the pos~-absorptive state, exer- 
cising on the bicycle ergometer or the motor driven 
treadmill at exactly measured work loads of from 20% 
to 90~ of the subject 's previously measured maximal 
oxygen uptake (max ~rO~) level. The disappearance of the 
infused glucose and of the consequently elevated concen- 
trations of plasma imm~moreactive insulin (IRI) was 
different after different work loads ; i.e. exercise of greater 
severity resulted in an increased rate of disappearance 
for both the glucose and the insulin. The variation in 
disappearance rate was not  dependent upon either the 
total  energy utilization or the t~tal carbohydrate utiliza- 
t ion during the exercise. I n  addition, the variations in 
glucose t~lerance were found to be almost independent  
of the durat ion of the preceding exercise, in that  severe 
exercise for as little as one minute  resulted in nearly the 
same glucose and insulin responses to glucose infusion as 
did exercise to exhaustion at the same work load. On the 
other hand, the rate of disappearance of the infused glu- 
cose was found to depend upon the rate of energy utiliza. 
tlon, or upon the rate of carbohydrate utilization ; i.e. the 
severity of the exercise work load in relation to the indi- 
vidual 's  max x~VO 2. Apparently, mechanisms which axe 
responsible for the removal of infused glucose after exer- 
cise are activated very early in the exercise, and the 
magnitude of the activation appears ~o depend upon the 
relative severity of the exercise. 
A growth hormone factor in human urine. 
tL F. Hanssen. Steno Memorial ttospital,  2820 Gentofte, 
Denmark. 
By using a double ant ibody radloimmunoassay on human 
urine, ultra~iltrated and lyophillzed, a factor is revealed 
which displaces i25I-HGH from HGH antibody. The factor 
has been further investigated and it is concluded that  it  
is not  due to salts. The factor is diluted as expected in a 
H G H  ra~liolmmunoassay tip to 1 : 16, then the concentra- 
t ion of the factor is below the sensitivi~-y of the assay; 
TZe recovery of added HGH was 78, 90 and 9 6 ~  respecti- 
vely. By using differsnt volumes of urine for ultrafiltration 
and tyophilizing, the recovery was found to be 4- 10% of 
the expected 4- 10%. 
By measuring plasma H G H  and the factor in urine slmul- 
taneously after HGXK injection in normal and hypopitui- 
tary subjects, a proportionality between plasma HGH and 
the factor in urine was established. The excretion of the 
factor was increased in aeromegalia and was diminished in 
adult  hypopituitarism. In  9 normal subjects it  was found 
to be between 28--53 mg/24 h urine when the factor was 
measured in  a radioimmunoassay for HGH. 
'I~e method has been used to s4udy the plasma H G t t  
compared with the excretion of the factor in urine in new- 
ly diagnosed diabetics before and  after initial t reatment.  
These results will be discussed. 
Some aspec~ on the production of amyloid in the islets of 
La~lgerhaus. 
P. Westermark. Department  of PathologT, University of 
Uppsala, Uppsala, Sweden. 
Hyalinization of the islets of Lamgerhans is accepted by  
marly authors as a form of amyloidosis. I t  is also accepted 
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that  amyloid is produced by cells at the site of deposition. 
Experimental  results have shown reticuloendothclial cells 
to be those that  most probably produce amyloid. In  the 
islets of Langerhans the amyloid is possibly produced by  
connective tissue cells. We have had an impression of an 
increase of mast  ceils in islets ~dth amyloid deposits and 
have therefore studied this quantitatively.  
I n  sections of pancreas from 9 patients with maturi ty-  
onset diabetes and 12 control cases the degree of amyloi- 
dosis in the pancreatic islets was measured and the mast 
cells were counted. In  8 diabetic and 7 control eases a vary- 
ing degree of amyloidosis was shown. I n  the control cases 
without amyloidosis of the islets the intra-insular mast  
cell count was 19.1 __ 3.0/ram a. The mast  cell count in 6 
control cases with slight islet amyloidosis ( <  2%) was 
31.6 ~ 3 .3/mm 2 and this difference was significant (P < 
0.02). In  the total  material  an increasing number  of mast  
cells was found as the degree of amyloidosis increased 
(r = 0.75; P < 0.01). The most severe amyloidosis and 
the largest number  of mast  cells were found in some dia- 
betic cases. 
I t  is conceivable tha t  the mast  cells are of some importance 
in the formation of amyloid in the pancreatic islets, bu t  
other explanations for the numerical increase in mast  cells 
are possible. 
Gastrointestinal hormones and the secretion of glucagon 
and insulin from the isolated, perfused canine pancreas. 
J. Iversen. Second Universi ty Clinic of In ternal  Medicine, 
Kommunehospitalet ,  J~rhus, Denmark. 
Using the isolated, perfused canine pancreas preparation, 
the interrelationship of the secretion of pancreatic glu- 
cagon and insulin was studied following stimulation with 
glucose, gastrointestinal hormones and the amino acid 
arginine. 
The results confirm the concept of a role of pancreatic 
iglucagon as a "hormone of glucose need" and suggest tha t  
t may be important  in a moment  to  moment  control of 
glucoregulation. The secretion of pancreatic glueagon was 
stimulated following infusion of gastrin, pancreozymin 
and arginine, whereas no increase was associated witah 
secrctin infusion. The magnitude of the increase was 
closely related to the glucose concentration present in the 
perfusion medium, being higher and more pronounced dur- 
ing perfusion with low concentrations of glucose (25 rag/ 
100 ml or 50 rag/100 ml). 
Stimulation of insulin secretion was seen following glu- 
cose, gastrln, pancreozymin, secretin and arginine. The 
magnitude of the increase was again closely related to the 
glucose concentration present, this time being higher and 
more pronounced during perfusion with high glucose con- 
centrations (150 rag/100 ml). 
Secretion of both pancreatic hormones always followed a 
biphasic response pat tern after the stimuli mentioned, 
similar to the characteristic release pat tern  previously 
described for insulin after an increment in glucose con- 
centration. 
I n  order to elucidate whether endogenous pancreatic 
glueagon possesses an insulinogenie action in  vivo, as it  
has been shown to be the case with the administrat ion of 
exogenous pancreatic glucagon, the time interrelationship 
of the secretion of pancreatic glueagon and insulin was 
investigated by  determining the initial rise of the hor- 
mones following st imulation with gastrin, pancreozymin 
and arginine. The rise of ghicagon and insulin occurred 
simultaneously, i.e. inside a 10 second perind.We are well 
aware, however, tha t  this does not  exclude with certainty 
an insulinogenic action of pancreatic glucagon. 
Glucose uptake by the pancreatic t~-cells. 
I.-B. T~Lljedal, B. tIel lman, J. Sehlin. Department  of 
Histology, Universi ty of Ume&, Ume&, Sweden. 
Uptake of glucose by micro-dissected pancreatic islets of 
obese-hyperglycaemic mice was studied at 8 ~ C. The use of a 
double-label procedure permitted correction for label in 
the extraeellular space. L-Glucose was restricted to the 
sucrose space, whereas D-glucose was uniformly equili- 
brated over the t-cell membrane. L-glucose (5--~0 raM) 
had no effect on the uptake of D-glucose (1 mM). 
Uptake of D-glucose was saturable with Vmax about  400 
mmoles/h per kg dry islet, and with Km around 50 lnSL 
At a medium concentration of 5 mM D-gluco~, the uptake 
of this sugar was almost completely blocked by 10 mM 
phlorizin. Under similar conditions 20 mM mannoheptu-  
lose had no significant effect on D-glucose uptake. 
The results contradict the previous hypothesis that  the 
/?-cell membrane is freely permeable to D-glucose. I t  is 
suggested that  uptake of ghlcose by these cells is mediated 
by a membrane-located transport  molecule with stereo- 
specificity for D-glucose. Renewed at tent ion should there- 
fore be given to the t-cell membrane as a possible locus 
for the triggering of insulin release by D-glucose. 
Modification of the pancreatic ~-cell function by phlorizin. 
B. Hellman, A. Lernmark, J. Sehlin, I.-B. T~iljedal. De- 
par tment  of Histology, University of Ume&, UmeA, Swe- 
dell. 
The effects of phlorizin on several parameters of t-cell 
function were studied with microdissected islets of obese- 
hyperglyeaemie mice. At a concentration of 10 rmM, phlori- 
zin significantly depressed insulin release, glucose trans- 
port, glucose oxidation and the level of fructose 1.6- 
diphosphate, when tested in the presence of 10 mM glu- 
cose. Whereas 1 mM phlorizin inhibited glucose transport  
by about 50~o, the glucose-stimulated insulin release 
remained unaffected by 1 -- 5 mM phlorizin. In  the absence 
of glucose, 10 mY phlorizin significantly stimulated insu- 
lin release bu t  had no effect on the islet levels of glucose 
6-phosphate or frnc4ose 1.6-diphosphate. The results 
corroborate our previous hypothesis of a mediated glucose 
transport  into the pancreatic /if-cell. Insul in release does 
not  seem to be governed by the glucose t ransport  in toto. 
Stimulation of insulin release might rather he elicited by  
the binding of glucose to a distinct membrane receptor, 
which accounts for bu t  a minor fraction of the total  glu- 
cose uptake. 
Modification of the pancreatic p-cell function by non- 
metabolizable, transport-specific amino acids. 
A. Lernmark, I-L N. Christensen, B. I-Iellman, J. Sehlin, 
I.-B. T/~ljedal. Department  of Histology, Universi ty of 
UmeA, Umes Sweden and Department  of Biological 
Chemistry, The Universi ty of Michigan, Ann Arbor, Michi- 
gan, U.S.A. 
The insulin-releasing abili ty and uptake characteristics 
of non-metabolizable, transport-specific amino acids were 
studied in vitro, using microdissected pancreatic islets 
containing more than  90% t-cells. Among the four stereo- 
isomers of 2-aminobicyelo(2, 2, 1)heptane-2-carboxylie 
acid IBCH), only the b(-) form stimulated insulin release. 
This isomer is known as a specific substrate for t ransport  
system/5 in other cells. I t  was rapidly taken up by  the 
islet ceils and stimulated insulin release both in the 
presence and in the absence of glucose. 4-Amino-I-guanyl- 
piperidine,l-carboxylic acid (PGA), a substrate for ca- 
tionic transport  systems, stimulated insulin release in the 
presence but  not  in the absence of glucose. In  this respect 
PGA is similar to arginine. Like arginine, PGA also 
accumulated in the islet cells to yield distribution ratios 
well above unity.  The results are consonant with the hypo- 
thesis that  amino acids stimulate insulin release by  bind- 
ing to specific transport  molecules. 
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ATP content in perifused pancreatic islets. 
L.-A. Idahl. Department  of Histology, University of 
Ume~, Ume&, Sweden. 
A multi-channel perifusion system was used to s tudy the 
dynamics of ATP regulation in microdissected islets from 
obese-hyperglycaemic mice. Islets were assayed for ATP 
at different time intervals before and after an abrupt  
change of the glucose concentration in the medium from 
0.6 mg/ml to 3.0 mg/ml. The amounts of glucose and 
insulin in the effluent h-ore the perifused islets were also 
recorded. At the end of a pro-incubation period (45 rain), 
the islets from animals starved for 18 h contained about 
3 mmoles of ATP per kg dry weight. This level remained 
constant throughout the subsequent 45-rain period of 
stimulation with 3.0 mg/ml glucose. Similar experiments 
with islets from fed animals revealed a significant increase 
in ATP within 3 min after exposition to the high glucose 
concentration. In  addition, the pro-incubation value was 
considerably higher in these islets (6.2 mmoles of ATP per 
kg dry weight) than  in islets from starved animals. These 
differences in ATP between islets from fed and starved 
animals might, perhaps, be related to the diminished in- 
sulin response that  has previously been observed after 
starvation. 
In Vitro uptake of 45Ca~+ by pancreatic iff-cells. 
J. Sehlin, B. Hellman, I.-B. T~ljedal. Department  of 
Histology, University of Ume&, Ume~, Sweden. 
The possible role of Ca ~+ in insulin secretion was investi- 
gated by studying the uptake of 45Ca2+ in microdissected 
pancreatic islets of obese-hyperglycemic mice. The inclu- 
sion of all-labelled manni tol  in the incubation media 
permitted correction for extracellular and contaminating 
45Ca2+ without washing the islets after incubation. Ex- 
change of Ca~+ was enhanced by increasing the medium 
concentration of glucose from 3 mM to 15 ml~I. However, 
glucose did not  affect the fl-cell content of 4~Ca~+ at 
equilibrium. Ca2+ uptake by fl-cells was also stimulated 
by sodium deficiency. These results are consistent with a 
sodium-dependent mechanism [for Ca ~+ transport  into the 
fl-cells that  may be of dfl'ect significance for insulin re- 
lease. 
Lysosomal activity and pancreatic jff-cell function. 
E. Gylfe. Department  of Histology, University of Ume'~, 
Ume&, Sweden. 
Lysosomes might participate in secretion processes by 
providing enzyme activities necessary for fusion of the 
secretory granules with the cell membrane. The possible 
role of lysosomes for insulin secretion was studied in crude 
lysosomal fractions isolated by differential centrifugation 
from the ~-cell-rieh pancreatic islets of obese-hypergly- 
caemic mice. Thermal labilization at 45~ was used to 
release particle-bound ~-glucuronidase and acid phos- 
phatase activities. These two lysosomal marker-enzymes 
were assayed fluorimetrically with 4-methylumbelliferone 
and umbelliferone substrates. The percentile release of 
particle-bound fl-glucuronidase after 60 min labilizaton 
of a crude lysosome fraction was 21.6 for islets, 51.5 for 
exocrine pancreas and 12.8 for liver. The higher percent- 
age for exocrine pancreas could at least in part  be attri- 
buted to the presence of a heat-labile factor, probably an 
enzyme. The hypoglyeaemie sulphonylurea compound 
glibcnclamide increased the release of particle-bound islet 
fl-glucuronidase and acid phosphatase. The liberation of 
particle-bound islet acid phosphatase was not, however, 
affected by  other modifiers of insulin secretion such as 
diazoxide, adrenaline and dibutyryl-3'.5'-cyclic AMP. 
Glucose metabolism of isolated pancreatic islets of neonatal 
rats. 
K. Asplund, C. Hellerstr6m. Histological Department,  
University of Uppsala, Uppsala, Sweden. 
In  the foetus and newborn of several species the stimulat- 
ing action of glucose on the insulin secretion is poorly 
developed or absent. This has boon particularly well 
demonstrated in the rat, in which studies both in vivo 
and in vitro have shown a deficient insulin secretory re- 
sponse to glucose up to the second postnatal  day. 
In  the present s tudy we have examined the rates of glu- 
cose oxidation, oxygen consumption and anaerobic gly- 
colysis in isolated islets from one and six days old rats. 
When incubated with 0.6 mg/ml glucose in the medium 
the islets from one day old rats showed a higher oxygen 
consumption than did those of the six days old animals. 
In  both groups of animals, the oxidation of glucose was 
considerably enhanced when the extracellular glucose 
concentration was raised from 0.6 to 3mg/ml.  The 
respiratory rate was correspondingly increased only in the 
older animals. Without  glucose in the medium the an- 
aerobic glycolytic rate was slightly higher in islets ob- 
tained from one day old rats compared with those of the 
older age group. At an extracellular glucose concentration 
of 3.0 mg/ml the anaerobic glycolysis was more enhanced 
in the islets of the one day old than in those of the six days 
old animals. 
These results indicate that  the inabili ty of the pancreatic 
B-cells to respond to glucose during foetal and early neo- 
natal  life should not  be primarily ascribed to a deficient 
ability of the foetal B-cells to phosphorylate and oxidize 
glucose. 
Quantitative measurements of enzymes involved in the 
turnover of fatty acids in the islets of New Zealand obese 
mice. 
Ch. Berne Histological Department,  University of Upp- 
sata, Uppsala, Sweden. 
Glucose is regarded as the main physiological stimulator 
of insulin release, bu t  amino acids, fat ty acids and possibly 
ketone bodies may also have a st imulatory effect. Little 
is known about the metabolism of fat ty acids and ketone 
bodies in the B-cells. In  order to evaluate the require- 
ments for lipid metabolism of the B-cells some enzymes 
involved in the turnover of fat ty acids have now been 
assayed in the islets. 
Enzyme assays have been performed in frozen-dried 
cryostat sections by means of Lowry's mierotechniques 
with fluorimetrie detection of reduced psaddine nucleo- 
tides. In  New Zealand Obese mice tissue samples have 
been examined from islets, exocrine pancreatic paren- 
chyma, liver, cardiac muscle and skeletal muscle. The 
islets showed the highest activity of beta-hydroxyacyl- 
CoA dehydrogenase among the tissues studied. The B-cells 
thus seem enzymatically equipped for a high rate of beta- 
oxidation of fat ty acids. ATP citrate lyase which provides 
cells with cytoplasmic 2-carbon fragments (in the form of 
acetyl-CoA) for fat ty acid synthesis showed a 4--5 times 
higher activity in the islets than in liver and cardiac 
muscle. The most important  pyridine nucleotide involved 
in fat ty acid synthesis is NADPH which is formed by  the 
hexose monophosphate shunt  of the B-cells. The other 
enzymes which influence the NADP/NADPH ratio, 
glutathione reductase, lqADP-dependent isocitrate de- 
hydrogenase and malic enzyme showed considerable 
activities in the islets also compared with the other 
tissues studied. In  conclusion; the islets seem enzymatic- 
ally well equipped for both the degradation and formation 
of fat ty acids. A fast turnover of the latter in the B-cells 
may be of importance in regulating the release of insulin 
and, in view of the intimate relationship between fat ty 
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acid metabolism and glucose break-down, also in the 
regulation of the glucose-mediated insulin release. 
Measurements of metabolic intermediates in the pancreatic 
islets by means of a photokinetic micro assay. 
S.E. Brolin, G. Wettermark. Histological Department,  
University of Uppsala, Sweden and Division of Physical 
Chemistry, Royal Inst i tute  of Technology, Stockholm, 
Sweden. 
Since the endocrine pancreas of mammals consists of 
numerous small islets, only minute  samples can be 
prepared for biochemical analyses. Determinations of 
enzyme activities, however, are facilitated by  a consider- 
able chemical magnification, consisting in the formation 
of several molecules of measurable product for each mole- 
cule of the enzyme. Assay of metabolic intermediates in 
samples composed of a limited number  of islets can be 
accomplished with enzymatic cycling. In  this way a mag- 
nification is obtained which equals the number  of cycles. 
Due to the possibilities of detecting low levels of light 
emission, applications of chemiluminescent reactions offer 
an alternative approach. Analytical skill in controlling 
cycling rates can then be replaced by  quali ty of the 
electronic instrumentat ion.  The light-producing reactions 
are initiated by rapid mixing of the reactants and followed 
by  photokinetic evaluation of the response. This is ac- 
complished by recording the time profile of the photo 
flash by means of a photomultiplier connected with an 
oscilloscope via a cathode follower. 
Firefly luciferase is suitable for measurements of the ATP 
and ADP content of the islets. In  our assay high ATP 
levels were found, which are in good accordance with 
those reported from experiments with enzymatic cycling. 
Bacterial luciferase is also sensitive enough for measure- 
ments at or below the picomole level which requires 
samples with a dry weight of about  0.i ~g. Since reduced 
pyridine nucleotides serve as measurable products, cou- 
pling to dehydrogenase reactions will enable a large 
number  of analytical applications. Micro methods for 
assay of malate and glucose are developed and can serve 
as examples of direct and coupled reactions. I t  is also 
possible to measure the oxidized form of pyridine nucleo- 
tides as demonstrated by determinations of the NAD 
content of the islets. This has been carried out after re- 
duction of the nucleotide with alcohol dehydrogenase. 
Aspects of glucagon content and enzymatic activities in 
the pancreatic A~-cells. 
G. Lundqvist .  Histological Department,  University of 
Uppsala, Uppsala, Sweden. 
Little is known about the metabolism of the As-cells, 
because of the difficulties to obtain pure samples of these 
cells. 
In  these studies sufficiant amounts  of Az-cells for micro- 
chemical analyses have been isolated by a microdisscction 
technique with dark-field stereo-microscopy. Horses, 
ducks and guinea-pigs were used because the cellular 
distribution in their islets is favourable for isolation of 
As-cells. 
The glucagon content of the As-cells of the horse, meas- 
ured by a radioimmunological technique, was found to be 
in the range of 3% of their dry weight, whereas glucagon 
was either absent or only present in trace amounts  in the 
B- and Al-cells and the pancreatic acini. 
The role of glucose in glucagon secretion have received 
much attention.  Hyperglycaemia inhibits the secretory 
response of the A2-cells, whereas hypoglycaemia is associ- 
ated with a rise in plasma glucagon, as observed in vivo. In  
order to study the relations between glucose metabolism 
and the secretory process, the capacity of glucose phos- 
phorylation of the glucagon-producing cells have been 
investigated, by using the Lowry microtechniques. Low 
hexokinase activity was observed in the  As-cells, com- 
pared with pancreatic acini and heart muscle. The ana- 
lyses were performed at high and low glucose concen- 
tration, and no high Kra hexokinase activity was found. 
Furthermore, the apparent Km value for the glucose 
phosphorylating enzyme of the As-cells was 3 to 4 x 10 s M. 
Certain enzymatic steps of the glycolysis were also studied 
with measurements of the activities of glyceraldehyde- 
phosphate dehydrogenasc, pyruvate kinase and phospho- 
glyceric kinase. These studies indicate tha t  the As-cells 
have a favourable enzymatic capacity for further con- 
version of glucose and glycolytic ATP formation. 
Since the degradation of free fat ty acids is of particular 
interest in the As-cells, the enzyme studies were extended 
to fl-hydroxyacyl-CoA dehydrogenase, one of the enzymes 
in the /?-oxidation of fatty acids. The activity of this 
enzyme was found to be higher in the As-cells than  in the 
exocrine pancreas, bu t  not  as high as in the B-cells. 
Oxidation of glucose and fatty acids in normal islets and in 
A2-cell rich islets from guinea-pigs. 
J. Edwards, C. Hellerstr6m, B. Petersson. Histological 
Department,  University of Uppsala, Uppsala, Sweden. 
I t  has previously been shown that  there are differences in 
the metabolic activities of normal guinea-pig islets and 
guinea-pig islets containing mainly A2-cells , which have 
been isolated after destruction of the B-cells with strepto- 
zotoein (Petersson, Hellerstr6m and Gunnarsson: Horm. 
Metab. Res., 2, 313, 1970). I n  further experiments, the 
production of 14C02 from the oxidation of ~4C-U-glueose 
and ~4C-l-oetanoate by  normal guinea-pig islets and by 
A2-cell rich islets has been investigated. 
I t  was found that  the rates of ~4C-glucose oxidation 
{per ~g dry weight) by normal islets and by As-cell rich 
islets were similar at 1.7 mM glucose. However, when the 
concentration of glucose was raised to 16.7 raM, the rate 
of 14C-glucose oxidation by normal islets increased by 
325% whereas l~C-glucose oxidation by  As-cell rich islets 
increased only 150% (P < 0.01). 
The rate of 14C0 s production from 14C-octanoate was found 
to be higher in As-cell rich islets (per ~g dry weight) than  
in normal islets (P<0 .05 ) .  In  the A2-cell rich islets, 
14C0s production from 14C-octanoate was higher than  
from 14C-glucose, and raising the concentration of 14C- 
octanoate from 0.5 mM to 5 mM caused an increase in 
14COs production of 600%. 
I t  is concluded that  guinea-pig islets containing a high 
proportion of As-cells oxidize octanoate more rapidly than 
glucose, and that  octanoate oxidation by  these islets 
responds markedly to changes in the extracellular con- 
centration of octanoate. Octanoate also appears to be 
readily oxidized by the B-cells of the guinea-pig. 
The correlation between the metabolism of oetanoate and 
glucose in the As-cells and B-cells, and the observed 
effects of these compounds on glucagon release (Edwards 
and Taylor, Biochim. Biophys. Acta, 215, 310, 1970) and 
insulin release (Montague and Taylor, Nature, 215, 853, 
1968) will be discussed. 
(J.E. is in receipt of a Wellcome-Swedish Travelling 
Research Fellowship). 
Frequency of diabetes after acute pancreatitis. Plasma 
insulin response to oral glucose. 
K. Johansen. Second University Clinic of In ternal  Medi- 
cine, .~_rhus, Denmark. 
Because of the possible therapeutic implications we have 
felt it  of importance to ascertain the frequency of diabetes 
after acute pancreatitis. At the same time we have studied 
the plasma insulin response to an oral glucose load to see 
whether diabetes due to acute pancreatitis is associated 
with a characteristic insulin response. 
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22 per cent of the  pat ients  had  a diabetic oral glucose 
tolerance test .  This is s tr ikingly higher than  the frequency 
found in the general populat ion in the Birmingham Survey 
(p < 0.01). 
I n  addi t ion i t  was found tha t  the blood glucose abnor- 
mal i ty  in the  diabetic  pat ients  was much less than  one 
would expect  in ordinary diabetes with the  same low 
plasma insulin responses. 
The possible implications of our findings as markers  to 
dist inguish genetic from non-genetic diabetes will be 
discussed. 
Peripheral blood flow and metabolic state in juvenile 
diabetics. 
H. ft. G. Gundersen. Second Univers i ty  Clinic of In terna l  
Medicine, Kommunehospi ta le t ,  Arhus, Denmark.  
The relationship between 4 metabolic parameters  (fasting 
blood sugar, F F A ,  St-HCO a and ur inary  glucose excretion) 
and blood flow in cutaneous, subcutaneous and muscular  
tissue in the  forearm was invest igated in 16 pat ients  with 
classic juvenile diabetes. 7 pat ients  had  newly diagnosed 
diabetes and were untreated,  the  remaining 9 pat ients  
had  diabetes for ~ - - 5  years. 
The pat ients  were invest igated both  during poor and good 
control conditions. In  all pat ients  the blood flow in cutan- 
eous and subcutaneous tissue was higher during poor 
control than  in good control state.  The mean blood 
pressure, the pulse rate,  the cutaneous tempera ture  and 
the body  tempera ture  were also elevated during poor 
control. 
The to ta l  forearm blood flow, i.e. muscular  blood flow, 
was higher during poor control in the 9 short- term dia- 
betics. In  contradist inct ion i t  was not  elevated in the  
newly diagnosed diabetics before insulin t rea tment  had  
been star ted.  
Plasma eatecholamines in juvenile diabetics 
1~1. J.  Christensen. The Second Clinic of In terna l  Medicine, 
Kommunehospi ta le t ,  Arhus, Denmark.  
Plasma adrenaline (A), p lasma noradrenaline (NA) and 
to ta l  plasma eateeholamine concentration (TPCA) have 
been measured in juvenile diabetics employing a precise 
and sensitive radio-enzymatic  assay. 
The following groups of subjects were examined in the  
recumbent  posit ion and 5 and 10 min after assuming the 
s tanding posit ion:  
1. 7 non-diabetic control subjects:  TPCA (mainly t~A) 
averaged 0.26 ng/ml in the  recumbent  posit ion rising to 
0.69 ng/ml (5 min) and 0.72 ng/ml ( i0 rain) after assuming 
the standing position. 
2 .9  long-term diabetics with neuropa thy :  TPCA averaged 
0.11 ng/ml in the recumbent  posit ion rising to 0.30 ng/m.1 
(5 rain) and to 0.37 ng/ml (10 rain) in the  s tanding posi- 
t ion. These mean values were all significantly reduced 
compared with the non-diabetic control subjects. 
3. 6 long-term diabetics without  neuropa thy :  values 
comparable wi th  the  non-diabetic  control subjects. 
4. 8 long-term diabetics with neuropa thy  hypophys-  
ectomized for diabetic re t inopathy.  TPCA (mainly nor- 
adrenaline) averaged 0.28 ng/ml in the recumbent  posit ion 
rising to 0.74 ng/ml (5 min) and 0.73 ng/ml (10 min) in 
the standing position. The mean values were significantly 
higher than  in the  diabetic control  subjects  (group 2). 
The significance of elevated plasma noradrenaline levels 
in hypophysectomized pat ients  for the beneficial effect 
of hypophysee tomy on diabetic re t inopa thy  and capil lary 
resistance is discussed. 
A number  of diabetics have also been s tudied during 
keto-acidosis, Both  A and NA increases considerably.  I t  
is possible tha t  circulatory changes in keto-acidosis are 
par t ia l ly  caused by  elevated p lasma adrenaline levels. 
Infusions of epinephrine to newly diagnosed, juvenile 
diabetics. 
K. Amman ,  S. CarlstrSm. Med. Klin.  A. Lasaret te l  Lund.  
Male, newly diagnosed, non-insulin t reated,  juvenile dia- 
betics and  control subjects were given infusions of 50 
micrograms epinephrine for ten minutes. The plasma 
concentrations of free f a t ty  acids (FFA) and glycerol and 
the blood glucose concentration were followed before, 
during and after the infusion period. I t  was found tha t  
both  the  p lasma F F A  and the plasma glycerol levels rose 
significantly more in the diabetic pat ients  than  in the  
controls. The blood glucose concentration rose signifi- 
cant ly  in the control group, bu t  concerning the diabetics 
no significant rise was noticed. 
In  earlier reports from this labora tory  i t  have been shown 
tha t  juvenile, non-insulin t rea ted  diabetics during a short  
period of exercise showed a higher rate  of lipid mobiliza- 
t ion than  controls. In  an a t t empt  to reveal how this 
exercise-induced, abnormal ly  high l ipid mobilization is 
mediated,  nor-epinephrine was infused in an earlier s tudy  
into diabetics of the same type  and into controls; in which 
study,  no significant difference in l ipid mobilization could 
be shown between the groups. The present s tudy suggests 
tha t  epinephrine m a y  act  as a mediator  for the abnormal ly  
increased l ipid mobil izat ion during exercise. The mean 
hear t  rate  during infusion was not  different in the diabetic 
and  the control group. 
Epinephrine is known to be a stronger beta-receptor  and a 
weaker alpha-receptor  s t imulant  than  nor-epinephrine. 
Fo r  tha t  reason, the  present findings m a y  support  the 
current  theory  tha t  the lipolysis in adipose tissue in man  
is ini t ia ted by  stimulus on the beta-receptors.  
Insulin response to oral glucose tolerance test in patients 
with pre-eclampsia. 
S./q. Madsen, I .  Hindberg,  L.M. Pedersen. Frederiksberg 
I-Iospital, Copenhagen. 
Oral glucose tolerance tests  (OGTT) with measurement  of 
serum insulin (Ii~I) were performed on normal  non- 
pregnant  women (n = 12), on normal  pregnant  women 
(n = 12) and on pat ients  with pre-eelampsia[(n = 12). All 
pat ients  were of normal  weight according to the tables of 
l~Iatvig. 
Pat ients  with pre-eclampsia were found to be high insulin 
responders after OGTT compared with the two normal  
groups, wi thout  impairment  of the blood glucose values. 
Glucose tolerance, plasma insulin and lipids in postmeno- 
pausal women during oestradiol valeratc treatment. 
K. PySr/il~, T. PySrala,  D. Weintraub.  Second Depart-  
ment  of Medicine, Univers i ty  of Helsinki, and Central 
Hospi ta l  of Middle Finland,  Jyv~skyla ,  Finland.  
Eight  postmenopausal  women aged 41 to 53 were t rea ted  
with an orally active oestrogen compound, oestradiol 
valerate,  using a cyclical dosage schedule. Each  t rea tment  
cycle consisted of 20 days  of oestradiol valerate t rea tment  
a t  a dai ly  dosage of 2 mg followed b y  a pause of 8 days. 
An oral glucose tolerance test  (OGTT) including plasma 
insulin determinat ions was carried out  before the t reat-  
ment.  Fas t ing  plasma cholesterol, tr iglyeeride and free 
fa t ty  acid levels were also determined.  These examinations 
were repeated after  3 - -4  months '  t rea tment .  Six women 
were examined also after 8--12 months '  t rea tment .  
Oestradiol valerate t rea tment  did not  cause any  signifi- 
cant  changes in blood glucose values during OGTT. 
Plasma insulin response tended to become slightly smaller 
during the t rea tment .  
P lasma cholesterol level showed a significant decrease 
(p < 0.02) after 3 - -4  months '  t r ea tment  and this t rend  
persisted after 8--12 months '  t rea tment .  Oestradiol 
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valerate t rea tment  did not  cause any  significant changes 
in plasma triglyceride and free fat ty acid levels. 
The results suggest tha t  oestradiol valcrate given to post- 
menopausal women at the dosage employed does not  
cause any unfavourable alterations in carbohydrate and 
lipid metabolism. 
Grant :  Pharmaceutical Manufacturers Leiras, I4uhta- 
m/~ki-yhtyma Oy, Turku, Finland.  
Normal blood sugar variation during pregnancy and in the 
early puerperium. 
A. Victor. Link6ping, Sweden. 
Several reports have shown that  a careful management  of 
the pregnant  diabetic lowers the risk of a fatal outcome 
for the expected child. I t  seems reasonable tha t  the goal 
for the management  should be to keep the mothers' blood 
sugar values as normal as possible during pregnancy. I t  
is know~l tha t  the fasting blood sugar level decreases and 
the insuIin response to a given glucose load increases 
during pregnancy. 
The aim of the present investigation was to find out what  
is a normal  blood sugar level during pregnancy. Four  
blood sugar values, the first after an over-night fast, were 
taken on 363 women in different stages of pregnancy. 
21 women were followed in the first puerperial week in 
the same manner.  The values obtained were compared 
with a normal material of 100 non-pregnant  women of 
childbearing age. 
I t  was found that  the blood sugar, fasting as well as non- 
fasting, steadily decreases during pregnancy. The mean 
fasting value decreases from 76 rag% to 67 rag% with 
+2S-va lues  of 91 and 84 rag% respectivly. The daily 
mean value decreases from a mean of I00 mg~/o (+2S 
120 mg~o) to 80 mg~o (+2S 99 mg~o). The ~-2S-value 
for the mean of the three nonfasting values never ex- 
ceeded 150 rag%. All decreases are highly significant as 
tested with ~he Students t-~est. In  the early puerperinm 
the blood sugar stays on the low level of late pregnancy. 
The reason for the lowered blood sugar level is no t  known, 
bu t  it is probable tha t  some factor (HPL ?) increases the 
sensitivity of the beta-cells in the islets of Langerhans. 
From a practical s tandpoint  it might be recommended 
that  the blood sugar of a pregnant  diabetic should never 
be allowed to exceed 145 rag% during the first two tri- 
o mesters and in the last should be kept under  120 mg ~o. 
The daily mean  value should never be let, over 110 r ag% 
and ideally should be kept  about 90 rag% and in  the last 
two months about 80 rag%. 
Neonatal diabetes becoming permanent. 
S. Oseid, O. Sovik, O. Aagenms. Pediatric Research 
Inst i tute,  Universi ty Hospital, Rikshospitalet, Oslo, 
Norway. 
A dysmature boy, b.w. 1846 g, with neonatal diabetes 
was presented at  our Stockholm meeting in 1968. A follow 
up of this patient  has shown, tha t  even if the fasting blood 
glucose values have remained normal, and a glucose load 
gives a normal  glucose curve, both on oral and i.v. glucose 
loads there are very sluggish and diminished I R I  re- 
sponses. 
A later born sister of this patient  was Mso dysmature,  b.w. 
1440 g. She showed a similar increase in blood glucose 
values as the brother in the neonatal  period, and insulin 
t rea tment  had to be started on day 12. At about  one year 
of age we succeeded in stopping insulin for some weeks, but  
fasting blood glucose values increased, and tolbutamide 
was successfully introduced about  5 weeks later. Fast ing 
I R I  levels have always been in the low normal  range. 
Repeated oral and i.v. glucose loading have shown dia- 
betic glucose and a very diminished IRI-response. 
Training Diabetics to Selfcontrol. 
C. Vagn-Hansen. Frydendal  15, Dk 6200, ~_benr&, Den- 
mark. 
A practical model in combination with fractionated 
urine-sugar analysis. The diabetic must  be taught  how 
insulin works and the mechanism of acidosis. By using a 
triangle with diet, insulin and physical exertion at  each 
corner, they are taught  about  each factor and their inter- 
relation. The pat ient  should then be able to localize the 
cause of positive urine-tests and correct it  himself, thus 
giving him more security and teaching him to interpret 
his own bodily reactions. The use of the Clinitest two-drop 
method and the not ing of the results in a book, with ex- 
planations of the positive tests, is advocated. Routine- 
tests are made every fortnight for two successive days, 
with tests four times daily. 
Metabolic effects of long-term glucagon infusion. 
I-I. Frey, D. Falch, K. Forfang, N. Norman, D. Fremstad.  
Medical Department B and Hormone Laboratory, Aker 
~ospital, Oslo, Norway. 
8 patients with chronic congestive hea1~ failure were given 
glucagon by continuous intravenous infusion for 96 h. 
The dose was 2 or 4 mg/h. 
In all .patients fasting blood sugar increased, maximal 
mean increase was 16 mg/100ml. Mean fasting serum 
immunoreactive insulin (IRI) increased relatively more 
(from 9.1 to 32.0 Inicrounits/ml), and mean fasting serum 
growth hormone rose from 2.8 to 11.9 ng/ml. 
During glueagon infusion, glucose disappearance rate fell 
considerably in all patients. In  spite of this, the I R I  
responses to the intravenous glucose were much higher 
than  before glucagon infusions, and serum growth hor- 
mone levels increased. 
Following a carbohydrate-rich meal, serum I R I  responses 
were much higher compared with the blood sugar during 
glucagon infusion than  before. The elevated levels of serum 
growth hormone were no t  suppressed by  the carbo- 
hydrate meal when the patients were under  glucagon 
treatment .  
In  conclusion, long-term infusion of large doses of gluca- 
gon leads to a state of mild diabetes mellitus in the pres- 
ence of resistance to endogenous insulin. The insulin 
resistance may be caused by increased levels of serum 
growth hormone. 
Latent coronary insufficiency in young diabetics. 
J. Jervell, L.S. Spitker. Medical Depar tment  B, Riks- 
hospitalet, Osto, Norway. 
Graded submaximal exercise electrocardiography was 
performed on a bicycle ergometer by 21 young diabetics. 
Average age 21 years, durat ion of diabetes 10--20 years. 
I n  6 ST-segment changes of the S-type were found during 
exercise, none had any  anginal pain, or ECG changes after 
work. Clinical and various laboratory investigations 
revealed no differences between the two groups. 
The results indicate that  coronary disease is present in a 
high proportion of young diabetics before clinical mani-  
festations appear. 
Potential and la~ent diabetes in connection with pregnancy. 
INT. O. Lunell, B. Persson. Karolinska Inst i tute ,  Stockholm, 
Sweden. 
The definitions of WHO, 1965 was used. Potential  dia- 
betic: A woman who has given birth to a baby  above 
4.5 kg or a stillborn with beta-cell hyperplasia. Latent  
diabetic: A woman with normal glucose tolerance (GT) 
known to have had a diabetic GT during pregnancy. 
However, further aspects, above all the durat ion of the 
pregnancy should be considered in connection with birth 
weight. 
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In  a retrospective s tudy (2) of 129 women who had given 
birth to babies above 4.5 kg intravenous glucose tolerance 
tests (IVGTT) were performed i0- -15  years later. 10% 
had asymptomatic diabetes (K ~ 1.0) and 4% had deve- 
loped overt diabetes. In  a control group of women with 
normal weight children no one had K ~ 1.0. This s tudy 
has now been repeated after further 5 years. In  both 
groups mean K had decreased significantly. 24% among 
mothers with LD had asymptomatic diabetes while 7% 
among mothers to normal weight infants had developed 
this stage. 
I t  would be advantageous if the diabetic stage could be 
revealed earlier. An IVGTT performed immediately after 
pregnancy is very seldom informative. However, s tudy 
of the newborn overweight infant,  having been exposed 
to a suspected decreased tolerance, might give more 
information. IVGTT in newborn normal infants give low 
K-values whereas infants of diabetic mothers show high 
K-values. In  a s tudy of 129 overweight infants 21% had 
IVGTT with highK-values (3). By analogy it is postulated 
that  the mothers of the infants with high K-values have 
had a diabetic carbohydrate tolerance during pregnancy. 
If a gestational diabetes, which we define as a t ransient  
diabetes during pregnancy with a K-value ~ 1.0 in an 
IVGTT, is found, she is supervised in hospital. The 
urinary oestriol excretion is followed. Labour is induced 
in the 40th week. Five women who had had a gestational 
diabetes were followed during t reatment  with oral anti- 
conception (OC) (4). IYGTT were performed during 
periods with and without OC. During OC there was a 
decreased tolerance which increased after medication was 
discontinued. Restraining with OC in latent  diabetics is 
advocated. 
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Perinatal  foetal mortal i ty  of the Copenhagen material  and 
on controlled therapeutical  trials. 
L.M. Pedersenog, ft. Pedersen. Med. afd. T., Bispebjerg 
Hospital, Copenhagen NV, Denmark. 
This contribution concerns some difficulties met  with in 
any  trial designed to show a statistically significant 
reduction in the perinatal  mortali ty of infants of diabetic 
mothers. 
The subject is illustrated with the 25 year case material of 
the Rigshospital centre consisting of 1164 deliveries in 
diabetics. The total  material is divided in three periods of 
time, and classified according to White and the PBSP 
classification. All of the perinatal mortalities are given 
with five per cent confidence limits. 
At the present time only controlled clinical trials should 
be acknowledged as a basis for any proposed new scheme 
of treatment.  The difficulty lies in the small number  of 
patients collected even in relatively big centres. Thus 
during the last five year period 1966--70, the perinatal 
mortal i ty was 12.6~o (9.0--16.2) in 318 pregnancies. 
In  e.g. White class C the perinatal mortal i ty was 8.2% 
(2.4-- 14.0) in 85 cases. Even without paying regard to the 
PBSP classification, or congenital malformations (25~o 
of neonatal  death) it would most probably take more than 
five years to conduct a proper controlled trial in this single 
White class in this centre. 
Although desirable such a s tudy is out of question. To 
save time it is necessary to use the total  material. A trial, 
therefore, must  be properly statistically designed be- 
forehand, including random allocation, stratification 
or analysis of covariance, and perhaps sequential analysis. 
The help of the statistician should be requested prior to 
the start  of a trial. 
Congenital  mal format ions  in the  offspring of diabetic 
w o m e n .  
L.M. Pedersen, I. Tygstrup, A.L. Villumsen, J. Pedersen. 
Med. afd. T., Bispebjerg Hospital, Copenhagen I~V. Den- 
mark. 
In  the centre for pregnant women with diabetes in the 
Royal Maternity dept. B, Rigshospitalet, Copenhagen the 
frequency of congenital malformations (c. m.) in the 
newborn infants of diabetic mothers has been consecu- 
tively and prospectively studied. 
Of 1335 infants born in the period 1926 to 1971 (birth 
weight i000 g or more) 8.1% had c. m. In  a consecutive 
control series of 8789 newborn infants of non-diabetic 
mothers born in the same hospital in the period September 
1959 to December 1961 c .m.  were found in 2.8%. No 
difference was found in the average and distribution of 
maternal  ages in the diabetic and the non-diabetic group. 
The number  of c .m.  in 106 infants born to diabetic 
mothers who came to necropsy after perinatal death in 
the period 1960 to 1971 was compared with that  in 1734 
infants of non-diabetic mothers (birth weight 1000 g or 
more) who were autopsied over the same period. In  the 
diabetic group there were 37.7% and in the non-diabetic 
13.7%. 
In  the newborn infants of diabetic mothers the over-all 
frequency and the frequency of major congenital mal- 
formations seem to be three to four times as high as in the 
general population. 
As previously reported by this group the frequency of 
c. m. was increased in infants of mothers with vascular 
complications (White's classes D and F). 
By comparison of the different types of malformations in 
the diabetic and non-diabetic materials we did not  find 
any "specific diabetic" malformation apart  from 3 cases 
with the combination of sacral agenesis and severe real- 
formations of the lower limbs. 
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